The National Cancer Institute has quietly moved a familiar and polarizing drug into its preclinical pipeline: ivermectin, ...

Things have been a bit awkward since the cancer hospital announced two-and-a-half years ago that it was breaking its ...

A lung cancer trial bolsters a long-held idea that treatment timing matters, showing a simple shift could help immunotherapy ...

Dana Farber Cancer Institute secures its largest gift to fund a new $1.68B inpatient cancer hospital opening in 2026 in Boston.

Specialty care company Lantern revealed it will expand its cancer care navigation platform through a new partnership with AccessHope. | Specialty care company Lantern revealed that it will expand its ...